Αποτελέσματα Αναζήτησης
INOVIO is a clinical-stage biotechnology company that develops DNA medicines and vaccines using proprietary technology and delivery devices. Learn about its pipeline, leadership, news and vision for DNA medicine.
- DNA Medicines Pipeline
DNA MEDICINES PIPELINE. INOVIO is leveraging a cutting-edge...
- Career Opportunities
INOVIO Pharmaceuticals, Inc. is committed to a policy of...
- Investors & Media
INOVIO is a clinical stage biotechnology company focused on...
- Stock Information
At INOVIO, we promise to treat your data with respect and...
- News Releases
At INOVIO, we promise to treat your data with respect and...
- Purpose, Mission and Values
INOVIO is a clinical-stage biotechnology company committed...
- About Inovio
About INOVIO . Purpose, Mission and Values; Leadership;...
- DNA Medicines Technology
OPTIMIZED DESIGN ANDDELIVERY, TEACHING THE BODY TO FIGHT...
- DNA Medicines Pipeline
Inovio is an American biotech company that develops synthetic DNA products for cancers and infectious diseases, including COVID-19. Learn about its technology, history, partnerships, and clinical trials of its vaccine candidates.
Get the latest stock price, news, quote and history of Inovio Pharmaceuticals, a biotechnology company developing DNA medicines for various diseases. See its products in pipeline, partners, performance, and more.
INOVIO is a biotechnology company developing novel DNA medicines and vaccines for infectious diseases and cancer. Learn about its technology, pipeline, clinical trials, publications, careers and more.
22 Οκτ 2024 · Find corporate information, presentations, publications, earnings, events, and stock quote of Inovio, a biotech company developing DNA medicines. Learn about its pipeline, technology, and focus on HPV-related diseases, cancer, and infectious diseases.
INOVIO uses proprietary technology to design and deliver DNA plasmids that teach the body to fight disease. Learn about the advantages, versatility and innovation of DNA medicines, including DNA-encoded monoclonal antibodies and DNA-launched nanoparticles.
1 Μαρ 2021 · With more than 3,000 patients receiving INOVIO investigational DNA medicines in more than 7,000 applications across a range of clinical trials, INOVIO has a strong track record of rapidly generating DNA medicine candidates with potential to meet urgent global health needs.
